SS Innovations International Inc. (SSII) AI Stock Analysis

SS Innovations International, Inc. operates as a commercial-stage surgical robotics company across India, the Philippines, Indonesia, South America, Iraq, Cyprus, Oman, the United Arab Emirates, Nepal, and internationally. Its core offerings include the SSi Mantra surgical robotic system and SSi Mudra stapling, energy, and core surgical instrumentations. The company also develops advanced systems such as the NADI Automated Coronary Anastomotic Connector, SSi Multi-Fire Clip Applier, and SSi Robotic Stapler. Digital solutions include the SSi Maya platform, SSi Guru tele-illustration, SSi XR Cognitive Skill Simulator, SSi Holographic Anatomy, and SSi Chitrasa. In addition, it provides accessories, telesurgery products, and 24/7 technical support services.

Revenue expanded from $1.5M in FY2022 to $5.9M in FY2023, $20.6M in FY2024, and $42.5M in FY2025, achieving a 3-year revenue CAGR of 207.7%. Annual revenue growth reached 105.7% in FY2025. Gross margin improved from 12.1% in FY2023 to 46.0% in FY2025. However, operating margin remained negative at -19.3% in FY2025, alongside net income of -$12.1M. For the trailing twelve months through June 30, 2026, revenue totaled $52.4M, supported by quarterly revenue growth of 39.4% year-over-year. Trailing operating margin was -16.3% and net profit margin was -23.7%.

As of June 30, 2026, the company held $13.6M in cash and short-term investments with total debt of $3.2M, yielding net cash of $10.4M. Shareholders' equity was $53.4M against total assets of $97.0M. The current ratio stood at 2.24 and debt-to-equity was 0.06. Operating cash flow in FY2025 was -$18.5M and free cash flow was -$22.2M, with capital expenditures of $3.7M. Over the past 5 years, the company's share count expanded by 9481.5%.

SSII closed at $2.53 on October 16, 2026, with a market capitalization of $507.2M and an enterprise value of $627.4M. The company trades at a price-to-sales multiple of 9.7x and an EV-to-revenue multiple of 12.0x, above the median of its US-listed Healthcare peers of 4.1x price-to-sales. Its price-to-book ratio is 11.7x. Over the trailing 1-year period, SSII declined 70.9%, trailing the S&P 500 (SPY) gain of 16.8%. The stock trades 37.4% below its 200-day moving average.

Wall Street coverage consists of 1 analyst maintaining a StrongBuy rating, with 0 Buy, 0 Hold, 0 Sell, and 0 StrongSell ratings. The mean price target is $7.00, representing 176.7% upside relative to the last close of $2.53. For the fiscal year ending December 31, 2026, consensus estimates project an EPS of -$0.06 on revenue of $59.6M. For the following fiscal year, revenue is projected at $76.2M, representing 27.9% growth, with EPS estimated at -$0.06. The company's next earnings date is October 27, 2026.

This page is an AI-written research summary of SS Innovations International Inc. (SSII). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: SSII income statement, SSII balance sheet, SSII key metrics, SSII analyst forecast, SSII chart. See the SSII stock overview for the latest quote and news.